acyclovir and Toxoplasmosis--Ocular

acyclovir has been researched along with Toxoplasmosis--Ocular* in 3 studies

Other Studies

3 other study(ies) available for acyclovir and Toxoplasmosis--Ocular

ArticleYear
[Bilateral toxoplasma retinochoroiditis secondary to primary infection in an immunocompetent patient].
    Journal francais d'ophtalmologie, 2018, Volume: 41, Issue:8

    Topics: Acyclovir; Adult; Alprazolam; Antimalarials; Aripiprazole; Chorioretinitis; Humans; Immunocompetence; Male; Pyrimethamine; Suicide, Attempted; Toxoplasma; Toxoplasmosis; Toxoplasmosis, Ocular

2018
[What is your diagnosis and treatment? Acute anterior uveitis without hypopyon].
    Journal francais d'ophtalmologie, 1998, Volume: 21, Issue:4

    Topics: Acute Disease; Acyclovir; Adult; Anti-Inflammatory Agents; Antiviral Agents; Dexamethasone; Diagnosis, Differential; Female; HLA-B27 Antigen; Humans; Intraocular Pressure; Iridocyclitis; Keratitis, Herpetic; Methylprednisolone; Mydriatics; Rheumatic Diseases; Toxoplasmosis, Ocular; Uveitis, Anterior

1998
[Retinitis in AIDS patients: diagnosis, follow-up and treatment].
    Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1989, Volume: 86, Issue:3

    Of 147 patients with AIDS (Walter Reed 3-6), 28 showed signs of retinal infection. Toxoplasmic retinochoroiditis had developed in 5 eyes of 4 patients, whereas cytomegalovirus (CMV) retinitis occurred in 40 eyes of 24 patients. All patients with toxoplasmosis complained of visual symptoms at the first visit, but only 60% of patients with CMV retinitis had ocular symptoms at this time. The important problems involved in making a timely and correct diagnosis (early CMV retinitis vs cotton wool spots vs toxoplasmic retinitis; significance of laboratory data) are presented and discussed. The course of CMV retinitis is sometimes fast and devastating and requires immediate treatment to prevent blindness in patients who are in otherwise still fair general health. Eighteen patients (28 eyes) were treated by intravenous ganciclovir (DHPG) for 1-9 months. Initial therapy (10 mg/kg body wt., 2-4 weeks) led to regression of fundus lesions in all eyes. Under maintenance treatment (5 mg/kg BW body wt., 5 times a week), 14 eyes still demonstrated significant regression or cicatrization of the lesions, 9 eyes showed little progress and 5 eyes moderate recovery. However, 8 of 12 untreated eyes became legally blind before the patient died. None of the 23 treated eyes with useful initial visual acuity (greater than or equal to 0.2) lost visual function. Only in three cases did the drug have to be stopped because of serious side effects (severe leukopenia, pancytopenia, psychosis). Toxoplasmic retinochoroiditis healed in all affected eyes after specific treatment (pyrimethamine, sulfamethoxydiazine, clindamycin, and spiramycin in double or triple combination).(ABSTRACT TRUNCATED AT 250 WORDS)

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Coccidiostats; Cytomegalovirus Infections; Drug Therapy, Combination; Follow-Up Studies; Ganciclovir; Humans; Male; Middle Aged; Opportunistic Infections; Retinitis; Toxoplasmosis, Ocular

1989